Vectus Biosystems Limited VBS.AX Stock
Vectus Biosystems Limited Price Chart
Vectus Biosystems Limited VBS.AX Financial and Trading Overview
| Vectus Biosystems Limited stock price | 0.25 AUD |
| Previous Close | 0.47 AUD |
| Open | 0.5 AUD |
| Bid | 0.45 AUD x 0 |
| Ask | 0.5 AUD x 0 |
| Day's Range | 0.5 - 0.5 AUD |
| 52 Week Range | 0.42 - 1.1 AUD |
| Volume | 2.5K AUD |
| Avg. Volume | 115.34K AUD |
| Market Cap | 26.59M AUD |
| Beta (5Y Monthly) | 0.947126 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VBS.AX Valuation Measures
| Enterprise Value | 16.46M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 14.151639 |
| Price/Book (mrq) | 4.385965 |
| Enterprise Value/Revenue | 8.76 |
| Enterprise Value/EBITDA | -5.62 |
Trading Information
Vectus Biosystems Limited Stock Price History
| Beta (5Y Monthly) | 0.947126 |
| 52-Week Change | -57.27% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.1 AUD |
| 52 Week Low | 0.42 AUD |
| 50-Day Moving Average | 0.51 AUD |
| 200-Day Moving Average | 0.69 AUD |
VBS.AX Share Statistics
| Avg. Volume (3 month) | 115.34K AUD |
| Avg. Daily Volume (10-Days) | 86.95K AUD |
| Shares Outstanding | 53.19M |
| Float | 19.62M |
| Short Ratio | N/A |
| % Held by Insiders | 45.02% |
| % Held by Institutions | 8.38% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -190.68% |
| Operating Margin (ttm) | -157.79% |
| Gross Margin | 100.00% |
| EBITDA Margin | -155.87% |
Management Effectiveness
| Return on Assets (ttm) | -38.39% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.88M AUD |
| Revenue Per Share (ttm) | 0.05 AUD |
| Quarterly Revenue Growth (yoy) | 723987.50% |
| Gross Profit (ttm) | 1.3M AUD |
| EBITDA | -2929385 AUD |
| Net Income Avi to Common (ttm) | -3583581 AUD |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 3.56M AUD |
| Total Cash Per Share (mrq) | 0.08 AUD |
| Total Debt (mrq) | 70.27K AUD |
| Total Debt/Equity (mrq) | 1.45 AUD |
| Current Ratio (mrq) | 5.989 |
| Book Value Per Share (mrq) | 0.114 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4027588 AUD |
| Levered Free Cash Flow (ttm) | -4106530 AUD |
Profile of Vectus Biosystems Limited
| Country | Australia |
| State | NSW |
| City | Rosebery |
| Address | 3-11 Primrose Avenue |
| ZIP | 2018 |
| Phone | 61 2 9381 1000 |
| Website | https://www.vectusbiosystems.com.au |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Vectus Biosystems Limited engages in the medical research and development activities in Australia. The company develops treatment for fibrosis and high blood pressure, which include treatments for heart, kidney, liver, and lung diseases. Its lead compound is VB0004, which is aimed at treating the loss of functional tissue to fibrosis, scarring, and high blood pressure. The company also intends to develop candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis and pulmonary fibrotic diseases. In addition, it develops AccuCal and RealCount software that enhance speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. The company was incorporated in 2005 and is based in Rosebery, Australia.
Q&A For Vectus Biosystems Limited Stock
What is a current VBS.AX stock price?
Vectus Biosystems Limited VBS.AX stock price today per share is 0.25 AUD.
How to purchase Vectus Biosystems Limited stock?
You can buy VBS.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vectus Biosystems Limited?
The stock symbol or ticker of Vectus Biosystems Limited is VBS.AX.
Which industry does the Vectus Biosystems Limited company belong to?
The Vectus Biosystems Limited industry is Biotechnology.
How many shares does Vectus Biosystems Limited have in circulation?
The max supply of Vectus Biosystems Limited shares is 53.21M.
What is Vectus Biosystems Limited Price to Earnings Ratio (PE Ratio)?
Vectus Biosystems Limited PE Ratio is now.
What was Vectus Biosystems Limited earnings per share over the trailing 12 months (TTM)?
Vectus Biosystems Limited EPS is -0.04 AUD over the trailing 12 months.
Which sector does the Vectus Biosystems Limited company belong to?
The Vectus Biosystems Limited sector is Healthcare.